Edward Mandel

Clarity in peptides? Don't hold your breath 🧪

Oct 1, 2026

•

7 min read

Clarity in peptides? Don't hold your breath 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

🧪Peptides and the boundary between supplements and drugs

Sep 24, 2026

•

3 min read

🧪Peptides and the boundary between supplements and drugs

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Will lack of testing derail peptide therapy market? 🧪

Sep 17, 2026

•

2 min read

Will lack of testing derail peptide therapy market? 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

🧪Questions consumers and clinicians ask TruthTide’s AI engine reveals interests and unknowns

Sep 10, 2026

•

4 min read

🧪Questions consumers and clinicians ask TruthTide’s AI engine reveals interests and unknowns

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

🧪Gyms provide a pathway to peptides, but can they do it legally?

Sep 3, 2026

•

4 min read

🧪Gyms provide a pathway to peptides, but can they do it legally?

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Managing the practitioner-pharmacy relationship 🧪

Aug 27, 2026

•

5 min read

Managing the practitioner-pharmacy relationship 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

🧪Lilly lashes out at peptide sellers but will regulators act?

Aug 20, 2026

•

5 min read

🧪Lilly lashes out at peptide sellers but will regulators act?

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

Longevity makes peptide therapy a "relationship" 🧪

Aug 13, 2026

•

8 min read

Longevity makes peptide therapy a "relationship" 🧪

By Rick Polito, Peptides Business Wire editor

Rick Polito, +1

How peptides are reshaping sports medicine 🧪

Aug 6, 2026

•

11 min read

How peptides are reshaping sports medicine 🧪

By Rick Polito, Peptides Business Wire editor

Edward Mandel, +1

Is legal access to peptides inevitable? 🧪

Jul 29, 2026

•

11 min read

Is legal access to peptides inevitable? 🧪

By Rick Polito, Peptides Business Wire editor

Edward Mandel, +1